Category: Management

  • The trial period to determine effective anti-inflammatory activity when starting a patient on…

    The trial period to determine effective anti-inflammatory activity when starting a patient on aspirin for rheumatoid arthritis is:
    48 hours
    4 to 6 days
    Four weeks
    Two months

  • Which assessment findings are characteristic of an individual with cachexia? Select all that…

    Which assessment findings are characteristic of an individual with cachexia? Select all that apply.
    Weight gain
    Early satiety
    Thermogenesis
    Increased appetite
    Altered metabolism

  • The patient says:”I’ve been going to have wastes filtered out of my blood by an artificia! kidney…

    The patient says: “I’ve been going to have wastes filtered out of my blood by an artificial kidney machine for four years.”
    You write: Patient reports requiring for four years.

  • Prescribed: Infuse 500mL lactated Ringers IV over 8 hoursDrop factor: 10gtts/mLAt what rate (mL/hr)…

    Prescribed: Infuse 500mL lactated Ringers IV over 8 hours
    Drop factor: 10gtts/mL
    At what rate (mL/hr) should the nurse set the infusion pump? Round to nearest whole number.

  • nursing care plan base on this diagnosis. Innefective airway cleance related to mucus secrtion…

    nursing care plan base on this diagnosis. Innefective airway cleance related to mucus secrtion thick and yellow: plan. intervention implementation, rational, and evaluation
    Diagnosis
    Ineffective airway clearance related to mucus secretion thick and yellow.
    Goal / Expected Outcomes
    Patient will maintain a patent airway as evidenced by clear breath sounds, effective cough, respiratory rate within baseline, and SpO2 ≥ baseline or ≥ 92% on room air (as appropriate).
    Mucus will be reduced in amount or become lighter in color and easier to expectorate within 24–48 hours.
    Nursing Interventions, Implementation, Rationale, and Evaluation
    Intervention
    Implementation
    Rationale
    Evaluation
    Assessment
    Assess respiratory rate, pattern, effort, and use of accessory muscles every 2–4 hours.
    Listen to lung sounds (anterior/posterior) for presence, location, and character of breath sounds and secretions.
    Monitor SpO2 and ABGs as ordered.
    Frequent assessment detects changes early and guides intervention intensity.
    Auscultation identifies areas of retained secretions or obstruction.
    Objective measures quantify oxygenation and ventilation status.
    Respiratory parameters stable or improved; breath sounds clearer; SpO2 within target range.
    Positioning
    Position patient upright or semi-Fowler to facilitate lung expansion and drainage.
    Change position every 2 hours to promote mobilization of secretions.
    Gravity assists in drainage and improves ventilation/perfusion matching.
    Frequent repositioning prevents pooling of secretions and reduces atelectasis risk.
    Patient tolerates position changes; decreased breath sounds of consolidation; easier expectoration.
    Airway clearance techniques
    Encourage effective coughing and teach directed (huff) cough techniques; provide support with splinting if post-op or painful.
    Perform chest physiotherapy (percussion, vibration, postural drainage) as ordered.
    Use incentive spirometry every 1–2 hours while awake if appropriate.
    Coughing mobilizes and removes secretions from the airway.
    Chest physiotherapy mobilizes secretions from peripheral to central airways for expectoration.
    Incentive spirometry promotes deep breathing, lung expansion, and mobilization of secretions.
    Patient demonstrates effective cough; secretions are expectorated; improved oxygenation and breath sounds.
    Humidification and hydration
    Provide humidified air or oxygen as ordered.
    Encourage oral fluids (if not contraindicated) to maintain adequate hydration.
    Humidification and hydration help thin thick secretions, making them easier to expectorate.
    Hydration reduces viscosity of mucus.
    Secretions become less viscous and are easier to clear; patient reports less difficulty expectorating.
    Suctioning (as needed)
    Perform oropharyngeal or tracheal suctioning using sterile technique when the patient cannot clear secretions or shows signs of airway obstruction (e.g., gurgling, decreased SpO2, increased work of breathing).
    Preoxygenate and limit suction duration to recommended intervals; monitor vitals during procedure.
    Suctioning removes secretions that the patient cannot clear, restoring airway patency.
    Preoxygenation prevents hypoxemia; limiting duration reduces trauma and vagal stimulation.
    Secretions removed; improvement in breath sounds and oxygenation; no adverse effects from suctioning.
    Medication management
    Administer bronchodilators, mucolytics, or expectorants as ordered (e.g., nebulized bronchodilators, acetylcysteine) and monitor response.
    Administer antibiotics if indicated by infection and ordered by provider.
    Bronchodilators open airways improving clearance; mucolytics reduce mucus viscosity; antibiotics treat underlying infection causing purulent secretions.
    Reduction in sputum production and improvement in respiratory status; fewer signs of infection if present.
    Oxygen therapy
    Provide supplemental oxygen as ordered to maintain target SpO2; titrate per protocol.
    Monitor for signs of CO2 retention in patients at risk.
    Oxygen improves tissue oxygenation while airway clearance measures take effect.
    Monitoring prevents complications in patients susceptible to hypoventilation.
    SpO2 maintained within target range; respiratory distress reduced.
    Patient and family education
    Teach techniques for effective coughing, breathing exercises, and use of devices (incentive spirometer, nebulizer).
    Instruct on importance of hydration, avoiding irritants (smoke), and when to seek help for increased difficulty breathing or fever.
    Education empowers patient to participate in airway clearance and prevents recurrence.
    Early recognition of worsening signs leads to timely intervention.
    Patient demonstrates technique and verbalizes understanding; adherence to recommendations reported.
    Documentation and coordination
    Document assessments, interventions, patient response, and sputum characteristics (color, amount, consistency, odor).
    Communicate changes to interdisciplinary team (respiratory therapy, physician) promptly.
    Accurate documentation ensures continuity of care and tracks progress.
    Timely communication facilitates escalation of care and appropriate ordering of therapies.
    Records reflect care provided and patient response; timely adjustments to plan made as needed.
    Evaluation
    Evaluate effectiveness of interventions by reassessing breath sounds, cough effectiveness, respiratory rate and effort, and oxygenation status after interventions and at regular intervals.
    Successful outcomes include clearer breath sounds, decreased or lighter secretions that are easily expectorated, improved SpO2, and patient report of easier breathing.
    If goals are not met, revise plan (e.g., increase frequency of airway clearance, consult respiratory therapy, consider further diagnostic testing or medication adjustments).

  • Regarding EHRs, which of the following is an administrative duty?creating patient…

    Regarding EHRs, which of the following is an administrative duty?
    creating patient correspondence
    generating pre-authorization forms
    organizing office finances
    informed consent

  • Give the generic name of this trade name drug and identify its drug category or what disease it is…

    Give the generic name of this trade name drug and identify its drug category or what disease it is used to treat. Trulicity Decadron Axiron Tapazole Cytomel Avandia Onglyza
    Trulicity
    : Generic — dulaglutide; Category/Use — GLP-1 receptor agonist, injectable antidiabetic for type 2 diabetes mellitus.
    Decadron
    : Generic — dexamethasone; Category/Use — corticosteroid (glucocorticoid) used to treat inflammation, allergic reactions, and as an immunosuppressant.
    Axiron
    : Generic — testosterone; Category/Use — androgen hormone replacement therapy for male hypogonadism (low testosterone).
    Tapazole
    : Generic — methimazole; Category/Use — antithyroid agent used to treat hyperthyroidism (e.g., Graves’ disease).
    Cytomel
    : Generic — liothyronine (T3); Category/Use — thyroid hormone replacement used to treat hypothyroidism (and in some cases myxedema coma).
    Avandia
    : Generic — rosiglitazone; Category/Use — thiazolidinedione (TZD) insulin sensitizer used to treat type 2 diabetes mellitus.
    Onglyza
    : Generic — saxagliptin; Category/Use — DPP-4 inhibitor, oral antidiabetic used to treat type 2 diabetes mellitus.

  • How do medications affect vital signs?Question 7 options:a) Has no effectb) Elevates the heart…

    How do medications affect vital signs?
    Question 7 options:
    a) Has no effect
    b) Elevates the heart rate
    c) Decreases the respirations
    d) May increase or decrease the vital signs

  • When must you document a persons response to a PRN medication?Immediately after administrationIn 30…

    ➤ What information should you record when documenting the response to a PRN medication?
    Record the medication name, dose, route, time given, and reason for PRN. Note baseline assessment, time-stamped response (pain score, vital signs, sedation), onset and duration of effect, any side effects or adverse reactions, refusal, and your name or initials. Include follow-up actions and communication with the prescriber when required.

  • True or False? Therapy services such as physical therapy, occupational therapy, and/or speech…

    True or False? Therapy services such as physical therapy, occupational therapy, and/or speech therapy are excluded from Medicare Part A or the consolidated billing process.